| Literature DB >> 28721810 |
Maria Grazia Caprio1, Karen Marr2, Sirin Gandhi2, Dejan Jakimovski2, Jesper Hagemeier2, Bianca Weinstock-Guttman3, Robert Zivadinov2, Marcello Mancini4.
Abstract
BACKGROUND: An impaired cerebrospinal venous drainage was postulated to be a cofactor in the multifactorial pathogenesis of multiple sclerosis (MS). Chronic cerebrospinal venous insufficiency (CCSVI) is characterized by abnormalities of the main extracranial cerebrospinal venous outflow routes, which can be detected by color Doppler Ultrasound (CDUS) using 5 venous hemodynamic (VH) criteria. Discrepant results between different investigators were reported in the past, therefore the usefulness and applicability of the CCSVI CDUS-based diagnosis in clinical research and practice has been questioned. The reproducibility of proposed criteria for CCSVI detection depends on the blinding, training level, skills of the operator and interpretation of VH criteria.Entities:
Keywords: CCSVI; Color doppler ultrasound; healthy controls; multiple sclerosis; reader agreement; venous hemodynamic criteria
Mesh:
Year: 2017 PMID: 28721810 PMCID: PMC5684782 DOI: 10.2174/1567202614666170718095203
Source DB: PubMed Journal: Curr Neurovasc Res ISSN: 1567-2026 Impact factor: 1.990
Demographic and clinical characteristics of multiple sclerosis patients and healthy controls.
|
|
|
|
|
|---|---|---|---|
| Female, n (%) | 17 (60.7%) | 56 (71.8%) | .277 |
| Age, mean (SD) | 50.3 (13.1) | 52.8 (9.9) | .307 |
| MS type | - | 42 (53.8%) | - |
| EDSS (Expanded Disability Status Scale), median interquartile range (IQR) | - | 3.5 (2.0-6.0) | - |
| Disease duration, mean Standard Deviation (SD) | - | 21.7 (10.1) | - |
| Relapses past 5 years, mean Standard Deviation (SD) | - | 1.03 (2.3) | - |
| BMI (Body mass index), mean Standard Deviation (SD) | 26.5 (5.4) | 27.9 (5.9) | .267 |
| Hypertension, n (%) | 5 (17.9%) | 10 (12.8%) | .466 |
| Hyperlipidemia, n (%) | 7 (25%) | 13 (16.7%) | .291 |
| Diabetes, n (%) | 1 (3.6%) | 3 (3.8%) | .955 |
| Heart disease, n (%) | 2 (7.1%) | 14 (17.9%) | .194 |
| Smoking†, n (%) | 9 (32.1%) | 40 (51.3%) | .095 |
Note: †Denotes whether subject has ever smoked. Disease modifying therapy use among MS subjects consisted of: non-therapy: 9, interferon-beta: 24, glatiramer acetate: 27, natalizumab: 4, other: 14.
P-values are derived from the Pearson chi-square test and student t-test.
Accuracy of CCSVI diagnosis and individual positive criteria between local and centralized reading center.
|
|
|
|
|
|
|---|---|---|---|---|
| Abnormal | 64 (60.4%) | 71 (67.0%) | .614 | <.001 |
| VH 1 | 2 (1.9%) | 3 (2.8%) | .795 | <.001 |
| VH 2 | 70 (66.0%) | 78 (73.6%) | .600 | <.001 |
| VH 3 | 21 (19.8%) | 16 (15.1%) | .576 | <.001 |
| VH 4 | 11 (10.4%) | 11 (10.4%) | .696 | <.001 |
| VH 5 | 89 (84.0%) | 91 (85.8%) | .926 | <.001 |
| MS | ||||
| Abnormal | 51 (65.4%) | 54 (69.2%) | .622 | <.001 |
| VH 1 | 2 (2.6%) | 3 (3.8%) | .794 | <.001 |
| VH 2 | 49 (62.8%) | 57 (73.1%) | .651 | <.001 |
| VH 3 | 17 (21.8%) | 12 (15.4%) | .537 | <.001 |
| VH 4 | 11 (14.1%) | 11 (14.1%) | .682 | <.001 |
| VH 5 | 68 (87.2%) | 69 (88.5%) | .940 | <.001 |
| HC | ||||
| Abnormal | 13 (46.4%) | 17 (60.7%) | .578 | .001 |
| VH 1 | 0 (0%) | 0 (0%) | 1 | <.001 |
| VH 2 | 21 (75.0%) | 21 (75.0%) | .429 | .034 |
| VH 3 | 4 (14.3%) | 4 (14.3%) | .708 | .001 |
| VH 4 | 0 (0%) | 0 (0%) | 1 | <.001 |
| VH 5 | 21 (75.0%) | 22 (78.6%) | .900 | <.001 |
Diagnostic accuracy (sensitivity, specificity, positive and negative predictive values, and the Odds Ratio) of Local (considered Gold Standard) vs centralized reader center.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Abnormal | 90.6% | 69.0% | 81.6% | 82.9% | 21.6 | <.001 |
| 1 or more* | 91.9% | 56.3% | 82.9% | 75.0% | 14.6 | <.001 |
| 2 or more* | 72.0% | 93.8% | 78.3% | 91.6% | 39.9 | <.001 |
| 1 positive** | 85.1% | 62.3% | 66.7% | 82.5% | 9.4 | <.001 |
| 2 positive** | 72.0% | 95.1% | 81.8% | 91.7% | 49.5 | <.001 |
| 3 positive** | 33.3% | 100% | 100% | 98.1% | 0.02 | <.001 |
| Criterion 1 | 100% | 99.0% | 66.7% | 100% | 3.0 | <.001 |
| Criterion 2 | 92.8% | 62.8% | 83.3% | 82.1% | 23.0 | <.001 |
| Criterion 3 | 57.1% | 95.3% | 75.0% | 90.0% | 27.0 | <.001 |
| Criterion 4 | 72.7% | 96.8% | 72.7% | 96.8% | 81.8 | <.001 |
| Criterion 5 | 100% | 88.2% | 97.8% | 100% | 45.0 | <.001 |
Criterion 5 that had higher sensitivity was demonstrated in more than 80% patients, but with low specificity (88.2%) for CCSVI diagnosis.
The best diagnostic accuracy between local and centralized readers was observed for VH criteria 4 followed by VH criteria 5.
Note: 95% confidence intervals are reported in parentheses.
*excludes Criteria 2. ** excludes criteria 1 and 2.